These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8341767

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol.
    Galinowski A, Poirier MF, Aymard N, Leyris A, Beauverie P, Bourdel MC, Loo H.
    Acta Psychiatr Scand; 1998 Jun; 97(6):458-66. PubMed ID: 9669519
    [Abstract] [Full Text] [Related]

  • 3. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
    Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL.
    Arch Gen Psychiatry; 1991 Oct; 48(10):910-3. PubMed ID: 1929760
    [Abstract] [Full Text] [Related]

  • 4. Dopamine turnover in schizophrenia before and after haloperidol withdrawal. CSF, plasma, and urine studies.
    Beuger M, van Kammen DP, Kelley ME, Yao J.
    Neuropsychopharmacology; 1996 Jul; 15(1):75-86. PubMed ID: 8797194
    [Abstract] [Full Text] [Related]

  • 5. Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia.
    Doran AR, Labarca R, Wolkowitz OM, Roy A, Douillet P, Pickar D.
    Arch Gen Psychiatry; 1990 Jun; 47(6):558-63. PubMed ID: 2350208
    [Abstract] [Full Text] [Related]

  • 6. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics.
    Duncan E, Wolkin A, Angrist B, Sanfilipo M, Wieland S, Cooper TB, Rotrosen J.
    Biol Psychiatry; 1993 Oct 15; 34(8):523-8. PubMed ID: 8274579
    [Abstract] [Full Text] [Related]

  • 7. Acute effects of neuroleptics on unmedicated schizophrenic patients and controls.
    Miller AL, Maas JW, Contreras S, Seleshi E, True JE, Bowden C, Castiglioni J.
    Biol Psychiatry; 1993 Aug 01; 34(3):178-87. PubMed ID: 8104509
    [Abstract] [Full Text] [Related]

  • 8. Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics.
    Kim YK, Kim L, Lee MS.
    Schizophr Res; 2000 Sep 01; 44(3):165-75. PubMed ID: 10962218
    [Abstract] [Full Text] [Related]

  • 9. Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patients.
    Davila R, Zumarraga M, Andia I, Friedhoff AJ.
    Life Sci; 1989 Sep 01; 44(16):1117-21. PubMed ID: 2565009
    [Abstract] [Full Text] [Related]

  • 10. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
    Kahn RS, Davidson M, Knott P, Stern RG, Apter S, Davis KL.
    Arch Gen Psychiatry; 1993 Aug 01; 50(8):599-605. PubMed ID: 7688208
    [Abstract] [Full Text] [Related]

  • 11. Short-term haloperidol administration acutely elevates human plasma homovanillic acid concentration.
    Davidson M, Giordani AB, Mohs RC, Horvath TB, Davis BM, Powchik P, Davis KL.
    Arch Gen Psychiatry; 1987 Feb 01; 44(2):189-90. PubMed ID: 3813816
    [No Abstract] [Full Text] [Related]

  • 12. Acute and chronic effects of neuroleptic drugs on plasma and brain homovanillic acid in the rat.
    Kendler KS, Davis KL.
    Psychiatry Res; 1984 Sep 01; 13(1):51-8. PubMed ID: 6151204
    [Abstract] [Full Text] [Related]

  • 13. Studies of catecholamine metabolism in schizophrenia/psychosis--II.
    Maas JW, Contreras SA, Miller AL, Berman N, Bowden CL, Javors MA, Seleshi E, Weintraub SE.
    Neuropsychopharmacology; 1993 Feb 01; 8(2):111-6. PubMed ID: 8471122
    [Abstract] [Full Text] [Related]

  • 14. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M, Kahn RS, Powchik P, Warne P, Losonczy MF, Kaminsky R, Apter S, Jaff S, Davis KL.
    Arch Gen Psychiatry; 1991 Jan 01; 48(1):73-6. PubMed ID: 1670618
    [Abstract] [Full Text] [Related]

  • 15. Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration.
    Csernansky JG, Barnes DE, Bellows EP, Lombrozo L.
    Life Sci; 1990 Jan 01; 46(10):707-13. PubMed ID: 2314192
    [Abstract] [Full Text] [Related]

  • 16. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M, Losonczy MF, Mohs RC, Lesser JC, Powchik P, Freed LB, Davis BM, Mykytyn VV, Davis KL.
    Neuropsychopharmacology; 1987 Dec 01; 1(1):17-23. PubMed ID: 3509064
    [Abstract] [Full Text] [Related]

  • 17. Plasma homovanillic acid as an index of brain dopamine metabolism: enhancement with debrisoquin.
    Sternberg DE, Heninger GR, Roth RH.
    Life Sci; 1983 May 23; 32(21):2447-52. PubMed ID: 6855448
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of haloperidol on negative symptoms in drug-naive schizophrenic patients: effects on plasma homovanillic acid.
    Labarca R, Silva H, Jerez S, Ruiz A, Forray MI, Gysling K, Andres ME, Bustos G, Castillo Y, Hono J.
    Schizophr Res; 1993 Mar 23; 9(1):29-34. PubMed ID: 8461269
    [Abstract] [Full Text] [Related]

  • 19. Pretreatment plasma HVA predicts neuroleptic response in manic psychosis.
    Mazure CM, Bowers MB.
    J Affect Disord; 1998 Feb 23; 48(1):83-6. PubMed ID: 9495606
    [Abstract] [Full Text] [Related]

  • 20. Plasma homovanillic acid levels and subtyping of schizophrenia.
    Chang WH, Chen TY, Lee CF, Hung JC, Hu WH, Yeh EK.
    Psychiatry Res; 1988 Mar 23; 23(3):239-44. PubMed ID: 3387499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.